www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

   

Import of AIDS drugs streamlined

By Shan Juan (China Daily)
Updated: 2007-12-03 07:48

The top food and drug agency is streamlining approval procedures for importing drugs to treat the estimated 85,000 patients in the country suffering from full-blown AIDS.

The move came after China released its HIV/AIDS prevalence and prevention assessment report for this year on Thursday, which stated that about 700,000 people in the country are living with AIDS and the HIV virus which causes the disease.

Zhang Wei, director with the drug registration department of the State Food and Drug Administration (SFDA), said his administration has always attached great importance to importing AIDS drugs.

"The approval work (for imported AIDS drugs) has never stopped," Zhang said.

He said a streamlined approval method has been adopted for imports of drugs that show significant clinical effects in treating diseases such as AIDS and cancer.

A regulation on drug approval was also amended in July making procedures more transparent and efficient, which could see certain procedures going faster in special cases.

It costs 120 working days to register an AIDS drug compared with 150 for most others, Zhang said.

Approval for the import of TDF, a key drug in the second line of anti-retroviral treatment also known as the cocktail therapy for AIDS, is currently under way and is expected to be completed in time, he said.

The United States-based Gliead, the drug's developer, filed the required application in August, said Zhang.

So far, only seven kinds of AIDS drugs mainly prescribed for first-line anti-retroviral treatment are available in China, with 37,497 AIDS patients reportedly getting free treatment with government aid.

About 10 percent of patients on the first-line treatment, however, develop resistance after taking the drugs for one year and have to switch to the second-line drugs to survive, said Hao Yao, deputy director with the disease control department of the Health Ministry.

To reduce the drug resistance also faced by AIDS patients in other countries, Hao strongly urged Chinese patients to stick to their treatment as many kinds of drugs in the second-line cocktail treatment such as TDF are still unavailable here and have to be imported from foreign countries.

"We are aware of the pressing issues and are considering further measures and policies," Zhang said.

Last week, the SFDA approved the import of Lopinavir/ritonavir, produced by the US-based Abbott Laboratories, which is also a crucial part of the second-line cocktail treatment.

In another development, the Ministry of Health has launched a pilot scheme on second-line therapy in Henan, Anhui and Hubei provinces, said Hao.

"This will be further expanded to the whole country," he said.



Top China News  
Today's Top News  
Most Commented/Read Stories in 48 Hours
主站蜘蛛池模板: 久久福利资源站免费观看i 久久高清精品 | 99久久国产免费 - 99久久国产免费 | 国产99视频精品免视看7 | 91精品成人免费国产 | 国产亚洲欧美日韩在线观看一区二区 | 91精品手机国产在线能 | 91久久99热青草国产 | 毛片网站视频 | 欧美成人毛片一级在线 | 福利视频黄| 中文字幕日本不卡 | 日韩精品欧美激情国产一区 | 欧美高清一级毛片免费视 | 欧美成人在线免费 | 成人免费视频网 | 热er99久久6国产精品免费 | 国产午夜精品理论片 | 黑人边吃奶边扎下面激情视频 | 国产免费怡红院视频 | 热99re久久精品精品免费 | 日韩欧美a级高清毛片 | 久久er热视频在这里精品 | 欧美在线视 | 美国一级毛片片免费 | 国产精品v欧美精品v日本精 | 日本免费三级网站 | 亚洲成a人片在线v观看 | 2022国内精品免费福利视频 | 91欧美视频 | 最新国产精品自拍 | 成人牲交一极毛片 | 一级特级aaaa毛片免费观看 | 欧美日韩永久久一区二区三区 | 一本色综合| 日本三级香港三级人妇 m | 欧美大片一区 | 日韩一级片免费看 | 一级做性色a爰片久久毛片免费 | 亚洲一区二区三区精品国产 | 日韩午夜精品 | 成人免费看www网址入口 |